dacarbazine has been researched along with Symptom Cluster in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (35.71) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 2 (14.29) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Alam, A; Mohile, N; Wasilewski, A | 1 |
Adeyi, O; Fung, S; Mason, M; Millar, BA | 1 |
Comet, B; Le Rhun, E; Ramirez, C; Reich, M | 1 |
Leo, F; Pastorino, U; Solli, PG; Spaggiari, L; Veronesi, G; Villa, G | 1 |
Garipidou, V; Kaloutsi, V; Perifanis, V; Tziomalos, K; Vakalopoulou, S; Zafiriadou, E | 1 |
Alba, E; Jurado, JM; Olmos, D; Rueda, A | 1 |
Duncan, LA; Fagadau, WR; Marynick, SP | 1 |
Badrinath, K; Banerji, M; Dorsch, TR; Lawrence, AM; Prinz, RA; Sparagana, M | 1 |
Galle, K; Schweiss, D | 1 |
Apak, H; Celkan, T; Ozbay, G; Ozkan, A; Yildiz, I; Yoruk, A | 1 |
Ando, K; Hayashi, S; Kimura, Y; Miyazawa, K; Mukai, K; Ohyashiki, K; Serizawa, H; Shimamoto, T; Yguchi, M | 1 |
Altundag, MK; Arpaci, F; Celasun, B; Kömürcü, S; Ozet, A; Oztürk, B; Tezcan, Y | 1 |
Aoki, TT; Strauss, GM; Weitzman, SA | 1 |
Altimari, AF; Bhoopalam, N; Lange, CL; O'Dorsio, T; Prinz, RA; Sandberg, L | 1 |
1 review(s) available for dacarbazine and Symptom Cluster
Article | Year |
---|---|
The vanishing bile duct syndrome in a child with Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Bleomycin; Child, Preschool; Dacarbazine; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Jaundice; Male; Syndrome; Vinblastine | 2001 |
13 other study(ies) available for dacarbazine and Symptom Cluster
Article | Year |
---|---|
Chemotherapy toxicities and geriatric syndromes in older patients with malignant gliomas.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Glioblastoma; Glioma; Humans; Retrospective Studies; Syndrome | 2021 |
Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
Topics: Antineoplastic Agents, Alkylating; Biopsy, Needle; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestyramine Resin; Common Bile Duct Diseases; Dacarbazine; Female; Follow-Up Studies; Glioblastoma; Humans; Immunohistochemistry; Jaundice; Liver Function Tests; Middle Aged; Syndrome; Temozolomide; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Cotard's syndrome with glioblastoma multiforme.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Corpus Callosum; Dacarbazine; Delusions; Depressive Disorder, Major; Glioblastoma; Humans; Male; Middle Aged; Prognosis; Psychotic Disorders; Suicide, Attempted; Syndrome; Temozolomide | 2012 |
Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung; Mechlorethamine; Pneumonectomy; Prednisone; Procarbazine; Prognosis; Radiography, Thoracic; Radiotherapy; Respiratory Distress Syndrome; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Syndrome; Tomography, X-Ray Computed; Vinblastine; Vincristine | 2002 |
Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Inflammation; Lung Diseases; Syndrome; Tomography, X-Ray Computed; Vinblastine | 2005 |
Presentation of Hodgkin's lymphoma with Ophelia syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Syndrome; Tomography, Emission-Computed, Single-Photon; Vinblastine | 2007 |
Malignant glucagonoma syndrome: response to chemotherapy.
Topics: Adenoma, Islet Cell; Dacarbazine; Female; Glucagon; Humans; Middle Aged; Pancreatic Neoplasms; Streptozocin; Syndrome | 1980 |
Operative and chemotherapeutic management of malignant glucagon-producing tumors.
Topics: Adenoma, Islet Cell; Body Weight; Dacarbazine; Dermatitis; Diabetes Mellitus; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Scotoma; Syndrome | 1981 |
[The glucagonoma syndrome--a not-so-well-known cutaneous paraneoplastic condition. Case report].
Topics: Adenoma, Islet Cell; Adrenal Cortex Hormones; Dacarbazine; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms; Precancerous Conditions; PUVA Therapy; Skin Neoplasms; Syndrome | 1984 |
Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy.
Topics: Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomycin; Bone Marrow; CD4-CD8 Ratio; Cell Lineage; Combined Modality Therapy; Cyclosporine; Dacarbazine; DNA, Neoplasm; DNA, Viral; Doxorubicin; Endothelial Growth Factors; Fever; Fibroblast Growth Factor 2; Gene Rearrangement, B-Lymphocyte; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammation; Interleukin-6; Lymph Nodes; Lymphokines; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Myelodysplastic Syndromes; Pancytopenia; Prednisolone; Remission Induction; Splenectomy; Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinblastine | 2001 |
Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestasis, Intrahepatic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Syndrome; Transplantation, Autologous; Vinblastine | 2002 |
Dimethyltriazenoimidazole carboxamide therapy of malignant glucagonoma.
Topics: Adult; Dacarbazine; Glucagon; Humans; Male; Pancreatic Neoplasms; Syndrome; Triazenes | 1979 |
Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Diabetes Mellitus; Drug Evaluation; Erythema; Female; Fluorouracil; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatin; Streptozocin; Syndrome | 1986 |